Contact information
Type
Scientific
Primary contact
Dr Nathan Congdon
ORCID ID
Contact details
Wilmer 120
600 N. Wolfe Street
Baltimore
21287
United States of America
ncongdon@jhmi.edu
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N/A
Study information
Scientific title
Acronym
INGOTT
Study hypothesis
Surgery will be more effective than medicines in controlling glaucoma in India
Ethics approval
Approved by the Internal Review Boards at the Johns Hopkins University, Baltimore, USA and the Aravind Eye Hospital in India
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Treatment
Patient information sheet
Condition
Glaucoma
Intervention
Medicine (timolol, latanaprost and brimonidine) versus surgery
Intervention type
Drug
Phase
Not Specified
Drug names
Timolol, latanaprost and brimonidine
Primary outcome measure
1. Intraocular pressure
2. Visual acuity
3. Quality of life
Secondary outcome measures
Cataract grade
Overall trial start date
01/01/2003
Overall trial end date
01/01/2007
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
Glaucoma patients over the age of 30 years in India
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
700
Participant exclusion criteria
1. Previous surgery
2. Intraocular pressure (IOP) >35
Recruitment start date
01/01/2003
Recruitment end date
01/01/2007
Locations
Countries of recruitment
India
Trial participating centre
Wilmer 120
Baltimore
21287
United States of America
Funders
Funder type
Industry
Funder name
Pfizer Inc.
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list